- Home
- SGLY vs SPRC Comparison
SGLY vs SPRC Comparison
Compare SGLY & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGLY
- SPRC
- Stock Information
- Founded
- SGLY 2001
- SPRC 2004
- Country
- SGLY United States
- SPRC Israel
- Employees
- SGLY N/A
- SPRC N/A
- Industry
- SGLY
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- SGLY
- SPRC Health Care
- Exchange
- SGLY Nasdaq
- SPRC Nasdaq
- Market Cap
- SGLY 3.0M
- SPRC 3.5M
- IPO Year
- SGLY 2008
- SPRC N/A
- Fundamental
- Price
- SGLY $0.71
- SPRC $0.29
- Analyst Decision
- SGLY
- SPRC
- Analyst Count
- SGLY 0
- SPRC 0
- Target Price
- SGLY N/A
- SPRC N/A
- AVG Volume (30 Days)
- SGLY 537.0K
- SPRC 180.7K
- Earning Date
- SGLY 05-26-2025
- SPRC 02-15-2025
- Dividend Yield
- SGLY N/A
- SPRC N/A
- EPS Growth
- SGLY N/A
- SPRC N/A
- EPS
- SGLY N/A
- SPRC N/A
- Revenue
- SGLY $2,255,541.00
- SPRC $1,306,000.00
- Revenue This Year
- SGLY N/A
- SPRC N/A
- Revenue Next Year
- SGLY N/A
- SPRC N/A
- P/E Ratio
- SGLY N/A
- SPRC N/A
- Revenue Growth
- SGLY N/A
- SPRC N/A
- 52 Week Low
- SGLY $0.54
- SPRC $0.20
- 52 Week High
- SGLY $7.65
- SPRC $1.79
- Technical
- Relative Strength Index (RSI)
- SGLY 47.25
- SPRC 44.27
- Support Level
- SGLY $0.65
- SPRC $0.25
- Resistance Level
- SGLY $0.68
- SPRC $0.31
- Average True Range (ATR)
- SGLY 0.10
- SPRC 0.02
- MACD
- SGLY 0.01
- SPRC 0.01
- Stochastic Oscillator
- SGLY 56.00
- SPRC 57.92
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.